| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvating the adjuvant: Facilitated delivery of an immunomodulatory oligonucleotide to TLR9 by a cationic antimicrobial peptide in dendritic cells
|
Aichinger, Michael C.
|
|
2011
|
29 |
3 |
p. 426-436
11 p.
|
article
|
| 2 |
Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting
|
Carvajal, A.
|
|
2011
|
29 |
3 |
p. 519-522
4 p.
|
article
|
| 3 |
Afriflu—International conference on influenza disease burden in Africa, 1–2 June 2010, Marrakech, Morocco
|
Steffen, C.
|
|
2011
|
29 |
3 |
p. 363-369
7 p.
|
article
|
| 4 |
A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: Safety and immunity
|
Lu, Chun-Chi
|
|
2011
|
29 |
3 |
p. 444-450
7 p.
|
article
|
| 5 |
A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedly
|
Sciaranghella, Gaia
|
|
2011
|
29 |
3 |
p. 476-486
11 p.
|
article
|
| 6 |
An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine
|
Lee, Yoon-Sook
|
|
2011
|
29 |
3 |
p. 417-425
9 p.
|
article
|
| 7 |
Attenuated Francisella asiatica iglC mutant induces protective immunity to francisellosis in tilapia
|
Soto, Esteban
|
|
2011
|
29 |
3 |
p. 593-598
6 p.
|
article
|
| 8 |
Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults
|
Silva, Maria Luiza
|
|
2011
|
29 |
3 |
p. 583-592
10 p.
|
article
|
| 9 |
Comparison of influenza vaccine effectiveness using different methods of case detection: Clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR)
|
Coleman, Laura A.
|
|
2011
|
29 |
3 |
p. 387-390
4 p.
|
article
|
| 10 |
Diphtheria–tetanus–pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau
|
Agergaard, J.
|
|
2011
|
29 |
3 |
p. 487-500
14 p.
|
article
|
| 11 |
Economic evaluation of infant and adolescent hepatitis B vaccination in the UK
|
Siddiqui, M. Ruby
|
|
2011
|
29 |
3 |
p. 466-475
10 p.
|
article
|
| 12 |
Editorial Board
|
|
|
2011
|
29 |
3 |
p. CO2-
1 p.
|
article
|
| 13 |
Effectiveness of the Q fever vaccine: A meta-analysis
|
Gefenaite, G.
|
|
2011
|
29 |
3 |
p. 395-398
4 p.
|
article
|
| 14 |
Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data
|
Sejvar, James J.
|
|
2011
|
29 |
3 |
p. 599-612
14 p.
|
article
|
| 15 |
High efficacy of anti DBL4ε-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women
|
Magistrado, Pamela A.
|
|
2011
|
29 |
3 |
p. 437-443
7 p.
|
article
|
| 16 |
Hospital initiation of a vaccinal schedule improves the long-term vaccinal coverage of ex-preterm children
|
Denizot, S.
|
|
2011
|
29 |
3 |
p. 382-386
5 p.
|
article
|
| 17 |
Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea
|
Cheong, Hee Jin
|
|
2011
|
29 |
3 |
p. 523-527
5 p.
|
article
|
| 18 |
Influence of patient's relationship status and HPV history on physicians’ decisions to recommend HPV vaccination
|
Zimet, Gregory D.
|
|
2011
|
29 |
3 |
p. 378-381
4 p.
|
article
|
| 19 |
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)
|
Hanquet, Germaine
|
|
2011
|
29 |
3 |
p. 370-377
8 p.
|
article
|
| 20 |
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity
|
Girvan, Rebecca C.
|
|
2011
|
29 |
3 |
p. 545-557
13 p.
|
article
|
| 21 |
MtsB, a hydrophobic membrane protein of Streptococcus iniae, is an effective subunit vaccine candidate
|
Zou, Lili
|
|
2011
|
29 |
3 |
p. 391-394
4 p.
|
article
|
| 22 |
“Once Bitten, Twice Shy”: Participant perspectives in the aftermath of an early HIV vaccine trial termination
|
Newman, P.A.
|
|
2011
|
29 |
3 |
p. 451-458
8 p.
|
article
|
| 23 |
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
|
Russell, F.M.
|
|
2011
|
29 |
3 |
p. 535-544
10 p.
|
article
|
| 24 |
Protection against avian metapneumovirus subtype C in turkeys immunized via the respiratory tract with inactivated virus
|
Cha, Ra Mi
|
|
2011
|
29 |
3 |
p. 459-465
7 p.
|
article
|
| 25 |
Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains
|
Ho, Mei M.
|
|
2011
|
29 |
3 |
p. 512-518
7 p.
|
article
|
| 26 |
Should I or Shouldn’t I: Decision making, knowledge and behavioral effects of quadrivalent HPV vaccination in men who have sex with men
|
Thomas, Emily A.
|
|
2011
|
29 |
3 |
p. 570-576
7 p.
|
article
|
| 27 |
Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo
|
Powell, Thomas J.
|
|
2011
|
29 |
3 |
p. 558-569
12 p.
|
article
|
| 28 |
The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003–2007)
|
Gil-Prieto, Ruth
|
|
2011
|
29 |
3 |
p. 412-416
5 p.
|
article
|
| 29 |
The use of green fluorescent protein as a marker for Brucella vaccines
|
Chacón-Díaz, Carlos
|
|
2011
|
29 |
3 |
p. 577-582
6 p.
|
article
|
| 30 |
The use of immunization registry-based data in vaccine effectiveness studies
|
Placzek, Hilary
|
|
2011
|
29 |
3 |
p. 399-411
13 p.
|
article
|
| 31 |
VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone
|
Moise, Leonard
|
|
2011
|
29 |
3 |
p. 501-511
11 p.
|
article
|
| 32 |
Worsening disparities in HPV vaccine utilization among 19–26 year old women
|
Dempsey, Amanda
|
|
2011
|
29 |
3 |
p. 528-534
7 p.
|
article
|
Journal description